Concepedia

Jennifer Postelnek

JP

Statistics

Publications

8

Citations

503

H-Index

8

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

La Roche College

Jennifer Postelnek is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, inflammation, and immunology.

ORCID

Publications per year

2004–2018

8

Publications

8

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Daigen Xu, Yong Kim, Jennifer Postelnek et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 141 citations

, , +17

Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation

Tai-An Lin, Kim W. McIntyre, Jagabandhu Das et al. · Biochemistry · 2004 · 113 citations · Full text

, , +17

Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase

Paola Mina‐Osorio, Jacob LaStant, Natalie Keirstead et al. · Arthritis & Rheumatism · 2013 · 82 citations

, , +17

Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors

Lillian L. Siu, Howard A. Burris, Dung T. Le et al. · Cancer Research · 2018 · 64 citations

, , +17

Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis

Connie Kliwinski, Daniel Kukral, Jennifer Postelnek et al. · Journal of Autoimmunity · 2005 · 42 citations

, , +15

1–5 of 8